Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin | Matthew Coldiron
1 Visualizações
• 06/15/23
0
0
Embutir
administrator
Assinantes
A study conducted in Mozambique shows pegylated liposomal doxorubicin (PLD) was safe, well-tolerated and effective as first-line treatment for Kaposi’s sarcoma, a common HIV-associated malignancy.
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários